(Q34074974)

30 July 2017

1 reference

title

Eniluracil: an irreversible inhibitor of dihydropyrimidine dehydrogenase (English)

1 reference

30 July 2017

Schilsky RL

1

1 reference

30 July 2017

Kindler HL

series ordinal

2

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 July 2000

1 reference

Expert Opinion on Investigational Drugs

30 July 2017

published in

1 reference

30 July 2017

volume

9

1 reference

30 July 2017

issue

7

1 reference

30 July 2017

page(s)

1635-1649

1 reference

A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.7.1635

5-Ethynyluracil (776C85): inactivation of dihydropyrimidine dehydrogenase in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.7.1635

5-Ethynyluracil (776C85): a potent modulator of the pharmacokinetics and antitumor efficacy of 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.7.1635

5-Ethynyluracil (GW776): effects on the formation of the toxic catabolites of 5-fluorouracil, fluoroacetate and fluorohydroxypropionic acid in the isolated perfused rat liver model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.7.1635

5-Ethynyluracil (776C85): protection from 5-fluorouracil-induced neurotoxicity in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.7.1635

alpha-fluoro-beta-alanine: effects on the antitumor activity and toxicity of 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.7.1635

Oral fluoropyrimidines: a closer look at their toxicities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.7.1635

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.7.1635

10.1517/13543784.9.7.1635

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference